Patents by Inventor Edgar Gelber

Edgar Gelber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of inhibiting cancer cells with ADNF III antisense oligonucleotides
    Patent number: 6649411
    Abstract: The present invention provides methods of using antisense ADNF III oligonucleotides to inhibit the growth of pathologically proliferating cells. The invention also provides methods and kits for using ADNF III nucleic acid probes to detect the presence of pathologically proliferating cells in human tissues.
    Type: Grant
    Filed: July 30, 1999
    Date of Patent: November 18, 2003
    Assignees: The United States of America as represented by the Department of Health and Human Services, Ramot at Tel-Aviv University Ltd.
    Inventors: Illana Gozes, Douglas E. Brenneman, Rachel Zamostiano, Edgar Gelber, Albert Pinhasov, Merav Bassan
  • Combination therapy with VIP antagonist
    Patent number: 6630124
    Abstract: The present invention relates to combination therapy using a pharmaceutical composition comprising a polypeptide which is an antagonist of the vasoactive intestinal polypeptide (VIP) and a chemotherapeutic agent. Methods of using the pharmaceutical composition are also disclosed.
    Type: Grant
    Filed: January 9, 2002
    Date of Patent: October 7, 2003
    Assignees: Ramot-University Authority for Applied Research and Industrial Development Ltd., Yeda Research and Development Co. Ltd., The United States of America as represented by the Department of Health and Human Services
    Inventors: Illana Gozes, Mati Fridkin, Edgar Gelber, Terry W. Moody, Douglas C. Brenneman
  • METHODS OF INHIBITING CANCER CELLS WITH ADNF III ANTISENSE OLIGONUCLEOTIDES
    Publication number: 20030036521
    Abstract: The present invention provides methods of using antisense ADNF III oligonucleotides to inhibit the growth of pathologically proliferating cells. The invention also provides methods and kits for using ADNF III nucleic acid probes to detect the presence of pathologically proliferating cells in human tissues.
    Type: Application
    Filed: July 30, 1999
    Publication date: February 20, 2003
    Inventors: ILLANA GOZES, DOUGLAS E. BRENNEMAN, RACHEL ZAMOSTIANO, EDGAR GELBER, ALBERT PINHASOV, MERAV BASSAN